Early detectionof aggressive prostate cancer through PSA testing may allow the disease to be treated early enough that it can be cured. PSA levels may be elevated 5–10 years before prostate cancer produces any symptoms. Early detection may also reduce the risk of complications due to the treatm...
The article presents an abstract regarding "Postoperative prostate specific antigen (PSA) decline predicts adequacy of adenoma removal with BPH surgical techniques," by P.J. Gilling, E.Fong, K.M. Kennett, A.M. Westenburg, L.Wilson and M.R. Fraundorfer. The study was conducted by ...
The U.S. Food and Drug Administration (FDA) initially approved the PSA blood test to monitor the progression of prostate cancer. In 1994, the FDA approved the test to be used as a screening tool to aid in the detection of prostate cancer in men 50 years or older. ...
Supersensitive PSA-Monitored Neoadjuvant Hormone Treatment of Clinically Localized Prostate Cancer: Effects on Positive Margins, Tumor Detection and Epithe... OBJECTIVE: The present study was done to investigate the effects of supersensitive PSA-controlled inductive treatment on positive margins, detection ...
In this chapter, a method for the analysis of prostate-specific antigen (PSA) by Capillary Zone Electrophoresis (CZE) with UV detection is detailed. High reproducibility in the separation of a large number of PSA isoforms is achieved by performing capillary conditioning in acid media and by ...
prostate‑specific antigen (tPSA) in human serum and plasma, is indicated for the measurement of total PSA in conjunction with digital rectal R1 Anti-PSA-Ab~biotin (gray cap), 1 bottle, 10 mL: examination (DRE) as an aid in the detection of prostate cancer in men Biotinylated monoclonal...
Whether patients can benefit therapeutically by the removal of LNM in prostate cancer is still inconclusive. In our group the complete PSA remissions after secondary resection of single LNM argue for a feasible therapeutic benefit. Nevertheless, the small number of cases and the comparative short foll...
Removal of the prostate resulted in a rapid, biexponential elimination of PSA-F from serum, corresponding to a mean initial (α) half-life of 0.81 hours and a mean terminal (β) half-life of 13.9 hours. Serum PSA-ACT concentrations decreased by 20% to 40% immediately after removal of ...
Introduction: PSA, in patients with BPH, is correlated with total prostate and transition zone volume. The decline in serum PSA levels may therefore be an important marker of completeness of tissue removal in patients undergoing invasive surgical procedures for BPH (Tinmouth et al 2005). In ...
Path. weight also correlated with symptom score improvement.Conclusions: BNI, laser ablation and microwave appear to result in less PSA decline and TRUS volume fall than after TURP and by inference less complete removal of adenoma. HoLEP gives larger % falls. A greater fall appears to be ...